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 The purpose of this study was to assess the impact of using an online personal 
health record (PHR) on clinical outcomes of patients with type 2 diabetes.  This study 
used an intervention mixed methods approach with a quantitative randomized, controlled 
trial combined with a qualitative exploration of how patients used the PHR.   A total of 
140 participants with type 2 diabetes were randomized to either receive a PHR and 
training to use the PHR, or to a control group who received usual care.  Both clinical and 
social cognitive outcomes were measured and compared at baseline and follow-up, three 
to six months after baseline.  A linear regression was also used to model the relationship 
between PHR use, social cognitive factors, and hemoglobin A1c (HbA1c).  The 
quantitative analysis revealed no differences in diabetes clinical outcomes (HbA1c or 
blood glucose) from baseline to follow-up between either the control and intervention 
groups, or within the intervention group, between individuals who continued to use the 
PHR after baseline (PHR users) and individuals who ceased use after baseline (PHR non-
users).  Additionally, the linear regression revealed no significant relationships between 
PHR use, social cognitive factors, and HbA1c.  In-depth interviews were conducted with 
all members of the intervention group to explore how patients used the PHR in their 
 
 
diabetes self-management.  Themes that emerged from the qualitative analysis were used 
to explain quantitative findings and identify continued research gaps that must be 
addressed in future research.  Nine themes emerged from the qualitative analysis, seven 
of which expressed barriers that helped to explain the lack of quantitative difference 
between the groups.  The additional two themes identified positive outcomes from PHR 
use that support hypothesized benefits from PHR use.  Future research should focus on 
the integration of the PHR into patients’ regular diabetes self-care routine and identifying 
which features of the PHR have the potential to lead to clinical improvement.   
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IMPACT OF STANDALONE PERSONAL HEALTH RECORD USE ON CLINICAL 
OUTCOMES OF PATIENTS WITH TYPE 2 DIABETES: AN INTERVENTION 
MIXED METHODS STUDY 
 
Chapter 1: Introduction 
Diabetes is the seventh leading cause of death in the United States, and continues 
to be the leading cause of kidney failure, non-traumatic lower-limb amputations, and new 
cases of blindness (Centers for Disease Control and Prevention (CDC), 2011).  There are 
currently 18.8 million Americans diagnosed with diabetes, with 40.3 million Americans 
(15.4% of the population) projected to have the disease by 2021 (CDC, 2011).  This will 
increase annual health care spending for diabetes from $206 billion to $512 billion (CDC, 
2011).   
 Despite the demonstrated efficacy of medical therapy in prevention of diabetes-
related complications, most patients with type 2 diabetes mellitus cared for in the 
community do not reach recommended treatment
 
goals for glycemic, blood pressure, or 
low-density lipoprotein
 
cholesterol (LDL-C) control established by the American 
Diabetes Association (Casagrande, Fradkin, Saydah, Rust, & Cowie, 2013; Saadine et al., 
2002; Saydah, Fradkin, & Cowie, 2004; UK Prospective Diabetes Study Group, 1998a; 
UK Prospective Diabetes Study Group, 1998b).  Teaching patients to monitor their 
diabetes risk factors, increasing patients’ knowledge about diabetes, and empowering 
them to collaborate with their physicians have been demonstrated to improve clinical 
outcomes (Anderson et al., 1995; Berikai et al., 2007; Heisler, Piette, Spencer, Kieffer, & 
Vijan, 2005; Rachmani, Levi, Slavachevski, Avin, & Ravid, 2002).  Older trials have 
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attempted to accomplish these goals through the use of patient-carried paper reminder 
cards and mini-records designed to help patients track the results of their care (Dickey & 
Petitti, 1992; Turner, Waivers, & O’Brien, 1990).  More recently, studies have used 
electronic tools to provide patients with personalized hemoglobin A1c (HbA1c) reports, 
glucose monitoring systems, and web-based case management (Cho et al., 2006; Levetan, 
Dawn, Robbins, & Ratner, 2002; McMahon et al., 2005).  In particular, personal health 
records (PHRs) have emerged as an innovative tool to empower patients to take an active 
role in their own health management (Tang, Ash, Bates, Overhage, & Sands, 2006).      
The Personal Health Record 
 The PHR is nationally-recognized as an electronic tool to facilitate patient self-
management of their health information, and subsequent sharing and exchange of that 
information with health care providers (Tang et al., 2006).  While there are many formal 
definitions of a PHR, what is common across all definitions is that the PHR is electronic, 
controlled by the patient, used for health information management, and should be secure 
and private (Fuji et al., 2012).  The PHR facilitates the existing interest by patients in 
tracking their personal health data, including self-treatments such as non-prescription 
medications and nutritional supplements, and self-monitoring results about health 
maintenance or progress (e.g. minutes exercised or weight loss) (Harris Interactive, 2004; 
Markle Foundation, 2003).  The PHR is expected to be a key component of the patient-
provider information network because it is patient-controlled and may contain 
information that is not available in the provider-based record (e.g. self-care behaviors, 
use of non-prescription medications or herbal supplements, etc.).  The PHR should 
provide a comprehensive view of the patient’s past and current medical history, including 
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treatment and care given by multiple providers (including non-traditional individuals 
such as herbalists), throughout the patient’s life.   
 There are a wide range of diverse PHR architectures and functions, ranging from 
“standalone” PHRs that do not integrate with any other electronic systems, to “tethered” 
PHRs that connect with a patient’s health care organization or health insurer (Tang et al., 
2006).  Tethered PHRs are expected to become increasingly used by patients as these 
types of PHRs are often connected to electronic health records (EHRs).  The “Meaningful 
Use” program, which has provided economic incentives to health care systems and 
providers to adopt and use EHRs, is designed to increase quality and safety of patient 
care through universal provider access to comprehensive patient information (Hillestad et 
al., 2005).  However, while this national initiative may lead to increased adoption of 
tethered PHRs, standalone PHRs will still be needed by patients whose provider does not 
utilize an EHR.   
 Regardless of architecture type, PHR use has been advanced as a strategy to 
facilitate improvements in diabetes self-management and achieve treatment goals (Grant 
et al., 2006; Hess et al., 2007; Osborn, Mayberry, Mulvaney, & Hess, 2010.  PHRs have 
the potential to enhance patient health knowledge, allow patients to better manage their 
medical conditions, and empower patients to become more involved in their care and 
share in decision-making with their providers, ultimately leading to better health 
outcomes (Nagykaldi, Aspy, Chou, & Mold, 2012; Solomon, Wagner, & Goes, 2012; 
Tang et al., 2006; Wagner et al., 2012).  Studies have also shown that patients believe the 
use of a technology such as a PHR will enable their health care providers to gain easier 
access to their health information, and will open channels of communication with other 
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health care providers and entities (Ball, Smith, & Bakalar, 2007).  It is even estimated 
that PHR use can result in health care cost savings.  A cost-benefit analysis of PHR use 
over 10 years demonstrated that although all PHR architectures have initial negative 
value, PHR use could yield annual savings of $13-21 billion per year (Kaelber & Pan, 
2008).  The promise of PHRs holds particular value for patients with chronic conditions 
such as diabetes, who have complex health needs; taking multiple medications and 
performing a variety of self-care behaviors to manage their condition(s) (Kaelber, Jha, 
Johnston, Middleton, & Bates, 2008; Solomon et al., 2012; Tang et al., 2006).     
 Despite these proposed benefits, it is estimated that only 10% of the consumers in 
the United States are using a PHR (Keckley & Coughlin, 2012).  It has been proposed 
that cost, concerns that information is not private or protected, inconvenience, design 
shortcoming and inability to share information across health care systems and 
organizations are potential barriers to PHR adoption and use (Kahn, Aulakh, & 
Bosworth, 2009).  However, many of these barriers are purely theoretical as there have 
been limited studies examining barriers experienced by actual PHR users.  Additionally, 
there has been limited research examining the impact of PHR use on clinical outcomes of 
chronic conditions amongst PHR users, and the studies that have been conducted have 
demonstrated inconsistent findings (Grant et al., 2006; Wagner et al., 2012).   
Studies Examining the Impact of a PHR on Clinical Outcomes of Diabetes 
To date, five studies have examined the use of a PHR (either alone or in 
combination with other interventions) and its impact on diabetes clinical outcomes, with 
mixed results. 
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Grant et al (2008) randomized 244 patients from 11 primary care practices into 
two tethered PHR groups (126 patients in the intervention group and 118 patients in the 
control group).  Intervention practices received access to a diabetes-specific PHR that 
allowed patients to view their clinical and medication-related information; provided 
patient-tailored decision support; and enabled the patient to author a “Diabetes Care 
Plan” for electronic submission to their physician prior to upcoming appointments.  
Control practices received a PHR that allowed patients to update and submit family 
history and health maintenance information.  After one year, there was no difference in 
HbA1c improvement between the intervention group (∆ = -0.16%) and the control group 
(∆ = -0.26%) (p = .62).   
Ralston et al (2009) randomized 83 patients to receive either web-based case 
management for diabetes along with access to a tethered PHR, or to usual care.  A total of 
74 patients completed the study (39 in the intervention group and 35 in the control 
group).  After one year, HbA1c improved significantly in the intervention group 
compared to the control group (∆ = -0.7%, p = .01).  However, the researchers were 
unable to determine to what extent the PHR specifically contributed to this change.   
Holbrook et al (2009) studied the impact of a tethered PHR with an automated 
telephone reminder system on diabetes quality of care.  The PHR contained a 
personalized diabetes tracker with identified treatment goals, and the telephone reminder 
system was used to remind patients of upcoming laboratory and physician visits.  The 
researchers randomized 511 patients to receive the intervention (n = 253) or to a control 
group (n = 258).  After six months, the intervention group had demonstrated a small but 
significant decrease in HbA1c compared to the control group (∆ = -0.2%, p = .029).  
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Similar to the study by Ralston et al (2009), the researchers were unable to determine to 
what extent the PHR specifically contributed to this change. 
Johnson & Singal (2006) examined the impact of a web-based health management 
system (which included a PHR) on diabetes quality of care outcomes in 254 patients (91 
in the intervention group and 163 in the control group).  The health management system 
provided patients with a personalized diabetes report card outlining treatment goals and 
progress toward achieving those goals, and also provided this information electronically 
to the patient’s health care provider.  After six months, patients in the intervention group 
saw their HbA1c improve significantly (∆ = -0.8%, p = .039) compared to the control 
group (∆ = +0.4%, p = .498).     
Tenforde et al (2012) conducted an observational study of patients with diabetes 
who used a tethered PHR with a secure messaging component and health reminders, 
compared to a control group of non-users.  A total of 4,036 patients were PHR users with 
6,710 patients comprising the control group.  After one year, patients who were PHR 
users demonstrated a lower HbA1c compared to patients who were not users (p < .01).  
However, as an observational study, the researchers could not make causal claims about 
PHR use and diabetes control.   
Current Gaps in the Literature 
Given the limited number of studies examining the impact of PHRs on diabetes 
outcomes and the difficulty in assessing the relative impact of PHRs compared to 
interventions it is often combined with, there is a need for further evaluation of the 
effectiveness of PHRs in patients with diabetes and an exploration of the unique 
contribution of PHRs.  Additionally, a focus should be placed on studying standalone 
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PHRs.  While tethered PHR adoption is increasing as EHRs are being adopted at a rapid 
rate, it is estimated that approximately 50% of physician offices and 20% of eligible 
hospitals still do not have EHRs, making further research on standalone PHRs an 
imperative (Kaelber et al., 2008; U.S. Department of Health and Human Services, 2013).    
Given the limited number of patients who have adopted a PHR, it is clear that 
health care is in an early phase of PHR use.  Thus, there is an opportunity to better 
understand the perceived value and challenges of PHR use from actual users (Kaelber et 
al., 2008).  There are few prospective studies designed to identify factors leading to 
sustained PHR use and barriers that lead to ineffective or non-use (Archer, Fevrier-
Thomas, Lokker, McKibbon, & Strauss, 2011; Kaelber et al., 2008; Ralston, Coleman, 
Reid, Handley, & Larson, 2010; Tenforde, Nowacki, Jain, & Hickner, 2012; Wagner et 
al., 2012).  A major question encompassing many of these issues is: How do patients 
engage with a PHR?  The proposed research will help to address above described gap in 
knowledge about the role PHRs play in diabetes-specific outcomes. 
Study Purpose and Research Questions 
The purpose of this study was to quantitatively assess the impact of a standalone 
PHR on clinical outcomes of patients with type 2 diabetes, qualitatively explore how 
patients with type 2 diabetes use a PHR to manage their diabetes-related health 
information for self-care, and use qualitative results to explain the quantitative findings.  
This will be accomplished through the following research aims: 
Quantitative Research Question: How does the use of a standalone PHR impact 
the clinical outcomes achieved in patients with type 2 diabetes compared to 
patients who use other methods of health information tracking? 
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Qualitative Research Question: How do patients with type 2 diabetes describe 
their use of a standalone PHR for managing their diabetes-related health 
information, including barriers to use and strategies for overcoming those 
barriers?  
Mixed Methods Research Question: How does the way in which patients with 
type 2 diabetes use the standalone PHR explain the impact of the standalone PHR 
on clinical outcomes of patients with type 2 diabetes? 
Chapter 2: Methods 
Research Design 
This comparative effectiveness pilot study utilized an intervention mixed methods 
study design, combining a randomized, controlled trial (quantitative component), with 
follow-up in-depth interviews (explanatory qualitative component) (see Figure 2.1).  It 
compared the effect of a PHR vs. traditional means of personal health information record-
keeping in achieving recognized clinical diabetes outcomes (primary outcome: change in 
HbA1c).  This study was approved by the Creighton University Institutional Review 
Board (IRB #09-15470).   
Intervention mixed methods design.  An intervention mixed methods design 
occurs in two phases, a primary quantitative phase that emphasizes the importance of 
statistical tests, examination of relationships between variables, and cause-and-effect 
(often typified through the conduction of a randomized controlled trial); and a qualitative 
phase designed to explain the results of the quantitative phase (Creswell & Plano Clark, 
2011; Song, Sandelowski, & Happ, 2010).  The quantitative phase takes priority over the 
qualitative phase, and quantitative data is collected and analyzed independently of 
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qualitative data.   The qualitative phase of the study is then conducted; collecting and 
analyzing the qualitative data.  Mixing of the data occurs during the data interpretation, 
after both the quantitative and qualitative data has been collected and analyzed.  
Qualitative findings are used to provide a deeper explanation for the quantitative results.  
Song, Sandelowski, and Happ (2010) identified limitations with the use of a 
randomized controlled trial when studying socially complex interventions, which may 
necessitate the use of an intervention mixed methods design.  Socially complex 
interventions are ones that are defined as having a large number of interacting parts; 
require complex behaviors for researchers providing the intervention and for participants 
engaging with the intervention; and a large number of different types of target outcomes 
resulting from intervention use (Craig et al., 2008).  Limitations to the randomized 
controlled trial in socially complex interventions include: 1) it is difficult to conduct a 
truly rigorous randomized controlled trial with random sampling and assignment, 
mutually exclusive study groups, and double blinding; 2) by definition, socially complex 
interventions are difficult to control and standardize, so the process of randomization 
itself may introduce a variable that impacts internal validity; and 3) it is difficult to 
generalize the results of a randomized controlled trial which is typically conducted in 
well-controlled settings, to understand the effectiveness of the intervention in a complex 
real-world setting (Song et al., 2010).     
Understanding these limitations, and identifying the PHR as a socially complex 
intervention, an intervention mixed methods design was chosen for this study.  While it is 
acknowledged that statistical changes in clinical outcomes are important because they can 
identify important relationships between variables and degrees of change, they are 
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incomplete on their own.  The addition of a complementary qualitative exploration to 
identify and explain reasons for the change (or non-change) is necessary (Creswell & 
Plano Clark, 2011).  This is particularly useful in the study of the PHR, a technology with 
limited evidence about its impact on clinical outcomes.  In this case, having a qualitative 
component also allows the researcher to explore a complex technology more in-depth and 
generate research questions for future study.   
Theoretical Framework 
A conceptual framework utilizing Bandura’s social cognitive theory (SCT) in 
health promotion was used to guide this study (Bandura, 1998).  Three study concepts 
were identified (modifying factors, diabetes knowledge, and self-efficacy) and then 
mapped to SCT concepts: modifying factors = outcome expectations + perceived 
facilitators; diabetes knowledge = knowledge; and self-efficacy = self-efficacy + goals.  
Modifying factors encompass perceived barriers which may interfere with managing 
diabetes care; and diabetes education and social support to assist patients in achieving 
optimal management of their diabetes.  Diabetes knowledge focuses on patients’ 
understanding of their condition and the improvements that can result from self-care 
behaviors.  Finally, self-efficacy is crucial as a patient with a high-degree of self-efficacy 
is more likely to engage in beneficial self-care behaviors compared to a patient with a 
low-degree of self-efficacy due to their confidence in being able to impact and change 
their diabetes self-management.   
 Within this framework, adoption and use of a PHR is hypothesized to have 
multiple effects.  The PHR provides a tool for patients to systematically track their health 
information.  Through the tracking of this information patients have the opportunity to 
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become more knowledgeable about their diabetes outcomes, recommended self-care 
behaviors, and how their actions can directly impact their outcomes or disease 
management (e.g. changes in blood glucose levels over time).  Observing positive 
changes resulting from improved self-care behaviors enhances patients’ confidence in 
their ability to self-manage their diabetes care and results in higher levels of self-efficacy.  
Thus, it is hypothesized that there is a linear relationship between PHR use, social 
cognitive factors, and improved HbA1c.  
Study Setting 
This study was conducted in three clinics located in a metropolitan, Midwest city.  
These three clinics consisted of two internal medicine practices and one endocrinology 
practice.  There are 13 practitioners at the clinic who provide regular diabetes care for 
patients (11 internal medicine physicians, 1 endocrinologist; 1 nurse practitioner).   
Participant Recruitment  
Medical record review was used to identify patients meeting the inclusion criteria: 
a diagnosis of type 2 diabetes with a hemoglobin A1c (HbA1c) value of ≥6.0, no 
concurrent diagnosis of impaired cognitive function (e.g. dementia), and English-
speaking.  Eligible patients were contacted via phone or met in-person immediately prior 
to their provider visit.  The study was described to patients who were asked to self-report 
if they had access to a computer and felt comfortable using a computer.  Those 
responding positively and were interested in participating provided informed consent and 
were enrolled in the study.  Participants were randomized to either the control group, who 
continued to receive usual care, or the intervention group, who were signed up for and 
trained on the use of an online PHR to manage their diabetes-related health information.   
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Study Intervention 
PHR selection followed a four step process: 1) identification of standalone PHRs 
that were free-of-charge and web-based; 2) identification of features that patients most 
desired in a PHR using an in-depth literature review; 3) creation of a checklist for 
evaluation of the identified PHRs; and 4) PHR evaluation using the checklist.  This 
process resulted in the selection of Microsoft HealthVault© as the study PHR. An in-
depth description of this process was published (Fuji et al., 2012).  While there are a 
number of PHRs that are fee-for-use, a free-of-charge PHR was chosen under the 
assumption that with the large number of PHRs available, patients were likely to select a 
PHR that does not incur personal expense.  
The Microsoft HealthVault PHR can be accessed online at: 
http://www.healthvault.com.  It allows users to enter in a wide range of health 
information from laboratory values to self-care behaviors.  Users can produce a visual 
graph of this information to track their progress over time.  Users can also choose to 
share selected pieces of health information with others of their choosing (e.g., their 
physician or a family member).  The PHR also has the ability to connect with a limited 
number of glucometers, allowing users to upload their blood glucose readings directly 
into the PHR, and to connect with some health-related applications.  The PHR does not 
provide any customized information to the individual and cannot be personalized in any 
way for use.       
Data Collection Tools 
Diabetes Care Survey. The Diabetes Care Survey was constructed as a hybrid 
instrument by: a) extracting relevant questions from previously-validated instruments; b) 
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using an unpublished instrument measuring knowledge of medical conditions and 
prescription medications; and c) developing new items. 
 Three existing instruments were identified that were relevant to the study aims: 
the Diabetes Care Profile, Diabetes Attitude Scale, and Diabetes Empowerment Scale 
(Anderson, Fitzgerald, Funnell, & Grupen, 1998; Anderson, Funnell, Fitzgerald, & 
Marrero, 2000; Fitzgerald et al., 1996).  Three researchers jointly reviewed each 
instrument and identified items that matched the study’s conceptual framework.  The 
researchers included a nurse, pharmacist, and clinical endocrinologist who provided 
content validity for the identified items.  A total of 79 items were selected from the 
Diabetes Care Profile, 13 items from the Diabetes Attitude Scale, and 13 items from the 
Diabetes Empowerment Scale.  An additional 2 items were added from a previously 
unpublished instrument measuring disease and medication knowledge, and 20 new items 
were developed to fill in concept gaps.  This process resulted in a 127-item survey.  
Twenty-four items measured modifying factors; 32 items measured diabetes knowledge; 
44 items measured self-efficacy; and the remaining 27 items addressing various self-care 
behaviors, access to care, and demographics.   
Medical record abstraction. A medical record abstraction sheet was developed 
to manually collect the following information from participants’ medical records: reason 
for the clinic visit; gender; age; year of diabetes diagnosis; weight; height; body mass 
index; most recent HbA1c value; most recent blood pressure; most recent blood glucose 
reading; most recent low-density lipoprotein, high-density lipoprotein, and triglyceride 
readings; most recent serum creatinine level; presence of diabetes-related complications 
(retinopathy, nephropathy, chronic renal failure, neuropathy, hypoglycemia 
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unawareness); list of current medical conditions; list of current medications; presence of 
diagnosed depression; date of last foot examination; date of last eye examination; date of 
last influenza vaccine; date of last pneumococcal vaccine; smoking status; alcohol 
consumption; and any other notes relevant to the participant’s diabetes care. 
Though the study will only analyze differences in HbA1c and blood glucose, 
collecting all of the clinical measures provides data for sub-analyses that will be 
necessary to build a more robust overall model for PHR use behavior that can be used in 
future studies.  In addition, all of this data is collected as a standard of care for patients 
with diabetes. 
Interview protocol. An interview protocol was developed to explore use of the 
PHR by participants in the intervention group (Creswell, 2013).  The central question 
guiding the interview was, “How have you used the PHR to manage your diabetes-
related health information?”  Questions were designed to gain a deeper understanding of 
the following topics: what the PHR was used for; how it fit into the participant’s life; the 
most useful aspects of the PHR; barriers to PHR use and strategies employed to 
overcome these barriers; how PHR use has changed diabetes self-care; how PHR use has 
changed the relationship with their diabetes care provider; and how PHR use has changed 
the way they track and manage their health information.  The interview protocol was 
pilot-tested with five individuals, all of whom had either diabetes or another chronic 
condition.  Changes were made to the protocol to clarify confusing phrasing and allow 
the interviewee to share additional information not explicitly solicited by the interviewer.   
Data Collection Process 
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Baseline.  All participants completed the Diabetes Care Survey and had data 
abstracted from their medical record once their diabetes care provider completed entering 
the care note for the patient’s visit in the clinic’s EHR.      
Participants in the intervention group received hands-on training for using the 
PHR.  A step-by-step instruction manual was created to guide the PHR training and was 
provided to participants for personal use.  It included screenshots from the PHR with 
accompanying written instructions guiding users through the process of signing up for the 
PHR and using it to maintain diabetes-related health information.  During training, the 
participant controlled a laptop computer while a researcher or research assistant provided 
instruction on using the PHR.  Participants were required to demonstrate the ability to 
enter the following information: birthdate, height, weight, medical condition(s), 
medication(s), blood glucose, blood pressure, HbA1c, low-density lipoprotein (LDL) 
cholesterol, and dates of last eye and foot exams.  During the PHR training, field notes 
were recorded about difficulties participants experienced or comments that provided 
insight into their perspective and behaviors towards diabetes self-care.  Participants were 
not directed to use the PHR in any specific way, but were given instructions to use it as 
needed to help manage their diabetes-related health information.   
Follow-up.  Follow-up visits were conducted 3-6 months after the baseline visit, 
corresponding to typical intervals for diabetes care visits (American Diabetes 
Association, 2013).  All participants again completed the Diabetes Care Survey and had 
data abstracted from their medical record once their diabetes care provider completed 
entering the care note for the patient’s visit in the clinic’s EHR.          
16 
 
All participants in the intervention group completed interviews, guided by the 
interview protocol.  This purposeful sampling procedure was used to ensure that the 
number of interviews conducted would greatly exceed the typical number needed to reach 
data saturation across qualitative designs (Patton, 2001; Sandelowski, 1995).  If a 
participant was not available immediately after their visit, the researcher or a research 
assistant conducted the interview over the telephone at a time mutually convenient to 
both the participant and the researcher.   
Data Analysis 
Quantitative data analysis. Quantitative data was analyzed using descriptive 
statistics for demographics, clinical outcomes, and social cognitive outcomes (both 
independent samples and paired t-tests to compare continuous variables and chi-square to 
compare categorical variables).  Due to the relatively small sample size, some 
demographic variables were dichotomized to allow for direct statistical comparison 
between both groups.  Each of the social cognitive factors was scored by summing 
participants’ responses to the corresponding items for the factor.  Higher scores indicated 
more positive characteristics.  The highest possible scores for each of the factors were: 
108 for modifying factors, 160 for diabetes knowledge, and 220 for self-efficacy.  
Additionally, participants in the intervention group were categorized as either “PHR 
users” or “PHR non-users”.  PHR use logs were examined, and any patient using the 
PHR at least once after baseline was classified as a PHR user.  A sub-analysis of PHR 
users and PHR non-users was also conducted to examine differences in clinical and social 
cognitive outcomes.    
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A linear regression was also run to determine the relationship between each of the 
different social cognitive factors, PHR use, and HbA1c using the following model: 
Effectiveness of care (HbA1c) = PHR use + modifying factors + diabetes knowledge + 
self-efficacy. 
Qualitative data analysis. Two of the study researchers participated in coding 
and analysis of the qualitative data.  The transcripts were analyzed using an iterative 
approach to data analysis, starting with multiple readings through each transcript to 
immerse the researcher in the data and gain an overarching perspective of participants’ 
responses (Hsieh & Shannon, 2005).  This data immersion also allowed the researchers to 
engage in reflexivity; reflecting on their own backgrounds and beliefs that could 
potentially bias their interpretation of participant interviews, and to gain awareness of 
these biases during the data analysis and interpretation (Creswell, 2013).  This was 
followed by individual coding of each transcript to identify key concepts.  Memoing and 
in vivo coding procedures were used to maintain the integrity of the participants’ own 
words and experiences (Miles, Huberman, & Saldana, 2014).  During this coding process 
each researcher referred to field notes from both the PHR training and the interview for 
each participant to gain additional context beyond the information available solely in the 
transcripts.  Researchers’ thoughts and insights were captured in notes made in the 
transcript margins next to each code.  These notes were used for further refinement.  
Once coding was complete, codes capturing similar ideas were grouped together to 
develop categories centered on patients’ use of the PHR to manage their diabetes-related 
health information.  The two researchers performing the data analysis met to compare 
categories and resolve differences in interpretation of coding leading to category 
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formation.  The researchers examined and discussed the relationships between the 
different categories using the central research question as a guiding framework for 
discussion.  Overarching themes emerged from examination of the relationships between 
categories.  Data saturation was achieved, and meaningful quotes were identified that 
were representative of each theme. 
Mixed methods data analysis. Mixing in this study occurred during the data 
interpretation phase.  Qualitative data from patients about their use of the PHR and self-
reported behaviors were used to explain the quantitative findings (change in HbA1c).    
Chapter 3: Results 
 A total of 117 participants completed the study, 61 members of the control group 
and 56 members of the intervention group.  The 23 participants who did not complete the 
study either asked to be removed from the study or did not return for a follow-up diabetes 
care visit within the study timeframe.  A total of 23 participants were classified as PHR 
users, and 33 participants were classified as PHR non-users.   
Quantitative Findings 
 Demographics.  Table 1 displays the demographic characteristics for the overall 
sample, with no statistically significant demographic differences between the control and 
intervention groups.   
Clinical outcomes for all participants.  At baseline, participants’ average 
HbA1c level was 7.69% with the control group having an average HbA1c level of 7.53% 
and the intervention group having an average HbA1c level of 7.86%.  There was no 
statistically significant difference between groups at baseline for HbA1c level (p = .301).  
At follow-up, participants’ average HbA1c level was 7.86% (∆ = +0.17%), with the 
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Table 3.1. Sample Demographics 
Demographic Characteristic Overall 
(N=117) 
Control 
Group  
(n=61) 
Intervention 
Group 
(n=56) 
P-value 
Age, years 59 59 59  
     
Years since diagnosis, years 12 11 13.5 .133 
     
Gender, n (%) 
Male 
Female 
 
53 (45.3) 
64 (54.7) 
 
32 (52.5) 
29 (47.5) 
 
21 (37.5) 
35 (62.5) 
 
.104 
     
Race, n (%) 
White 
African American or Hispanic 
 
89 (76.1) 
28 (23.9) 
 
47 (77.0) 
14 (23.0) 
 
42 (75.0) 
14 (25.0) 
 
.795 
     
Marital status, n (%) 
Married 
Single 
 
69 (59) 
49 (41) 
 
36 (59.0) 
25 (41.0) 
 
33 (58.9) 
23 (41.1) 
 
.992 
     
Level of education, n (%) 
Less than college graduate 
College graduate 
 
73 (62.4) 
44 (37.6) 
 
39 (63.9) 
22 (36.1) 
 
34 (60.7) 
22 (39.3) 
 
.719 
     
Income, n (%) 
Less than $70,000 
$70,000 or greater 
 
76 (68.5) 
35 (31.5) 
 
40 (69.0) 
18 (31.0) 
 
36 (67.9) 
17 (32.1) 
 
.906 
     
Employment status, n (%) 
Not currently working 
Currently working 
 
62 (53) 
55 (47) 
 
33 (54.1) 
28 (45.9) 
 
29 (51.8) 
27 (48.2) 
 
.802 
     
 
control group having an average HbA1c level of 7.75% (∆ = +0.22%) and the 
intervention group having an average HbA1c level of 7.98% (∆ = +0.12%).  There was 
no statistically significant difference between groups at follow-up for HbA1c level (p = 
.455).  A paired samples t-test revealed no statistically significant change in HbA1c from 
baseline to follow-up for either the control group (p = .252) or the intervention group (p = 
.535). 
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Blood glucose, a more transient measure of diabetes control was also assessed.  
At baseline, participants’ average blood glucose level was 174.9 mg/dL with the control 
group having an average blood glucose level of 173.7 mg/dL and the intervention group 
having an average blood glucose of 176.4 mg/dL.  There was no statistically significant 
difference between groups at baseline for blood glucose level (p = .864).  At follow-up, 
participants’ average blood glucose level was 177.4 mg/dL (∆ = +2.5 mg/dL) with the 
control group having an average blood glucose of 168.9 mg/dL (∆ = -4.8 mg/dL) and the 
intervention group having an average blood glucose of 186.9 mg/dL (∆ = +10.5 mg/dL).  
There was no statistically significant difference between groups at follow-up for blood 
glucose level (p = .233).  A paired samples t-test revealed no statistically significant 
change in blood glucose level from baseline to follow-up for either the control group (p = 
.901) or the intervention group (p = .397). 
Clinical outcomes for the intervention group.  At baseline, participants’ 
average HbA1c level was 7.86% with the PHR users having an average HbA1c level of 
7.46% and the PHR non-users having an average HbA1c level of 8.14%.  There was no 
statistically significant difference between groups at baseline for HbA1c level (p = .204).  
At follow-up, participants’ average HbA1c level was 7.98% (∆ = +0.12%), with the PHR 
users having an average HbA1c level of 7.78% (∆ = +0.32%) and the PHR non-users 
having an average HbA1c level of 8.12% (∆ = -0.02%).  There was no statistically 
significant difference between groups at follow-up for HbA1c level (p = .546).  A paired 
samples t-test revealed no statistically significant change in HbA1c from baseline to 
follow-up for either the PHR users (p = .338) or the PHR non-users (p = .901). 
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Blood glucose was also assessed in PHR users and non-users.  At baseline, 
participants’ average blood glucose level was 176.3 mg/dL with the PHR users having an 
average blood glucose level of 151.1 mg/dL and the PHR non-users having an average 
blood glucose of 193.7 mg/dL.  There was no statistically significant difference between 
groups at baseline for blood glucose level (p = .072).  At follow-up, participants’ average 
blood glucose level was 170.2 mg/dL (∆ = -6.1 mg/dL) with the PHR users having an 
average blood glucose of 156.5 mg/dL (∆ = +5.0 mg/dL) and the PHR non-users having 
an average blood glucose of 208.2 mg/dL (∆ = -14.5 mg/dL).  There was a statistically 
significant difference between groups at follow-up for blood glucose level (p = .022).  
However, a paired samples t-test revealed no statistically significant change in blood 
glucose level from baseline to follow-up for either the PHR users (p = .507) or the PHR 
non-users (p = .525). 
 Social cognitive outcomes for all participants.  At baseline, participants’ 
average score for modifying factors was 79.2 (out of a possible 108) with the control 
group having an average score of 81.8 and the intervention group having an average 
score of 76.4.  There was no statistically significant difference between groups at baseline 
for modifying factors (p = .334).  At follow-up, participants’ average score for modifying 
factors was 81.7 (∆ = +2.5) with the control group having an average score of 80.3 (∆ = -
1.5) and the intervention group having an average score of 83.3 (∆ = +6.9).  There was no 
statistically significant difference between groups at follow-up for modifying factors 
score (p = .138).  A paired samples t-test revealed no statistically significant change in 
modifying factors score from baseline to follow-up for either the control group (p = .274) 
or the intervention group (p = .238). 
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 At baseline, participants’ average score for diabetes knowledge was 133.1 (out of 
a possible 160) with the control group having an average score of 133.6 and the 
intervention group having an average score of 132.6.  There was no statistically 
significant difference between groups at baseline for diabetes knowledge (p = .638).  At 
follow-up, participants’ average score for diabetes knowledge was 134.6 (∆ = +1.5) with 
the control group having an average score of 134.1 (∆ = +0.5) and the intervention group 
having an average score of 135.2 (∆ = +2.6).  There was no statistically significant 
difference between groups at follow-up for diabetes knowledge score (p = .595).  A 
paired samples t-test revealed no statistically significant change in diabetes knowledge 
score from baseline to follow-up for either the control group (p = .695) or the intervention 
group (p = .098). 
 At baseline, participants’ average score for self-efficacy was 166.9 (out of a 
possible 220) with the control group having an average score of 165.9 and the 
intervention group having an average score of 167.9.  There was no statistically 
significant difference between groups at baseline (p = .497).  At follow-up, participants’ 
average score for self-efficacy was 167.9 (∆ = +1.0) with the control group having an 
average score of 167.4 (∆ = +1.5) and the intervention group having an average score of 
169.0 (∆ = -1.1).  There was no statistically significant difference between groups at 
follow-up for self-efficacy score (p = .627).  A paired samples t-test revealed no 
statistically significant change in self-efficacy score from baseline to follow-up for either 
the control group (p = .367) or the intervention group (p = .701).  
 Social cognitive outcomes for the intervention group.  At baseline, 
participants’ average score for modifying factors was 76.4 (out of a possible 108) with 
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the PHR users having an average score of 83.4 and the PHR non-users group having an 
average score of 71.5.  There was no statistically significant difference between groups at 
baseline for modifying factors (p = .298).  At follow-up, participants’ average score for 
modifying factors was 83.2 (∆ = +6.8) with the PHR users having an average score of 
85.6 (∆ = +2.2) and the PHR non-users group having an average score of 81.6 (∆ = 
+10.1).  There was no statistically significant difference between groups at follow-up for 
modifying factors score (p = .151).  A paired samples t-test revealed no statistically 
significant change in modifying factors score from baseline to follow-up for either the 
PHR users (p = .136) or the PHR non-users (p = .306). 
 At baseline, participants’ average score for diabetes knowledge was 132.6 (out of 
a possible 160) with the PHR users having an average score of 134.0 and the PHR non-
users having an average score of 131.7.  There was no statistically significant difference 
between groups at baseline for diabetes knowledge (p = .490).  At follow-up, 
participants’ average score for diabetes knowledge was 135.2 (∆ = +2.6) with the PHR 
users having an average score of 135.7 (∆ = +1.7) and the PHR non-users having an 
average score of 134.8 (∆ = +3.1).  There was no statistically significant difference 
between groups at follow-up for diabetes knowledge score (p = .770).  A paired samples 
t-test revealed no statistically significant change in diabetes knowledge score from 
baseline to follow-up for either the PHR users (p = .575) or PHR non-users (p = .063). 
 At baseline, participants’ average score for self-efficacy was 167.9 (out of a 
possible 220) with the PHR users having an average score of 170.8 and the PHR non-
users having an average score of 165.9.  There was no statistically significant difference 
between groups at baseline (p = .245).  At follow-up, participants’ average score for self-
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efficacy was 169.0 (∆ = +1.1) with the PHR users having an average score of 174.8 (∆ = 
+4.0) and the PHR non-users having an average score of 164.9 (∆ = -1.0).  There was a 
statistically significant difference between groups at follow-up for self-efficacy score (p = 
.027).  However, a paired samples t-test revealed no statistically significant change in 
self-efficacy score from baseline to follow-up for either the PHR users (p = .083) or the 
PHR non-users (p = .359).  
 Linear regression model.  A linear regression was conducted to model the 
relationship between the social cognitive factors, PHR use, and the primary outcome 
variable of HbA1c.  This analysis resulted in the following regression equation: 
HbA1c’ = 10.813 + (.224)PHR use + (.007)Modifying factors +  
(-.027)Diabetes knowledge + (-.002)Self-efficacy 
R
2
 = .035, and none of the social cognitive factors or the use of the PHR was a significant 
contributor to predicted HbA1c.  Regression data for the model is presented in Table 2. 
Qualitative Findings  
Qualitative data analysis yielded nine themes that reflect the mixed experiences of 
participants in the intervention group with PHR use.  The positive themes were: complete 
and accessible record; and increased awareness.  The negative themes were: double 
tracking; PHR design issues; out of sight, out of mind; economic, infrastructure, and 
computer literacy barriers; I would have used it if I were sicker; lack of patient-provider  
engagement; and security and privacy concerns.    
Theme 1: Complete and accessible record. Participants valued the PHR as a 
self-maintained, self-controlled complete and accessible record of their health 
information.  Participants described the PHR as their “personal data vault,” and 
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Table 3.2 Linear Regression Model for PHR Use, Social Cognitive Factors and HbA1c  
 B SE P-value 
Constant 10.813 1.988 .000 
    
PHR use .244 .307 .429 
    
Modifying factors .007 .018 .706 
    
Diabetes knowledge -.027 .019 .168 
    
Self-efficacy -.002 .014 .890 
 
“general overall record of my health.”  The PHR was helpful for participants who were 
not previously tracking their health information, or for those who only used their memory 
to remember their health information.  Participants also described targeted use of the 
PHR to track less frequent labs (e.g. lipids), while using their glucometer for daily blood 
glucose readings.  Other participants saw value in having all of their health information in 
one location accessible anywhere with Internet connectivity, illustrated by a participant 
recognizing the benefit in emergency situations stating, “if something happens and I 
needed medical records, now they can get it.” 
Theme 2: Increased awareness.  PHR use increased participants’ awareness of 
fluctuations in their diabetes care, primarily through the ability to graph blood glucose 
readings within the PHR.  This function made it easier for participants to see long-term 
cause-and-effect compared to on paper or a glucometer, illustrated by one participant 
sharing, “I like that I can track my glucose level and I can see what I’ve been doing and 
if food is what was causing me to have highs or lows.”  This longitudinal look at their 
diabetes progress was helpful for participants “to see where I was going and where I had 
been.”  PHR use highlighted potential areas for self-care improvement, which led some 
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participants to make behavioral changes.  One participant shared that, “it allowed me to 
adjust my insulin because if it [blood glucose levels] was too low then I wouldn’t take as 
much so it really did help me to manage that.”  Using the PHR led several participants to 
exercise more and lose weight, led one participant to begin monitoring her blood 
pressure, and another to share that using the PHR, “makes me check my sugars more like 
I’m supposed to.” 
Theme 3: Double tracking.  Participants still used other mechanisms for tracking 
their health information, including their memory, print-outs, handwritten records, 
Microsoft Excel, and their glucometer.  Participants expressed a comfort level with their 
existing mechanisms, so what was typical for the patient did not change with the 
introduction of the PHR.  An example was a patient who used the PHR but maintained 
use of his Excel file because, “being able to average and get my blood sugars in Excel is 
what I am used to.”  Participants noted that using the PHR takes an “additional step” 
(i.e. logging in) to record information compared to other mechanisms.  This contrast was 
viewed negatively, illustrated by a participant who stated, “just give me a piece of paper 
and I can write it down.”  Another participant described how she “put in a few things in 
the beginning, but I usually just keep it on paper.  It’s easier for me to just write it on 
paper where I test my blood sugar.”   
 Theme 4: PHR design issues.  There were multiple design-related issues that 
made the PHR difficult to use.  First, the PHR was difficult to navigate, even for simply 
locating the log-in page from the website homepage.  It was also demanding with its data 
entry requirements, forcing patients to assign unit labels for laboratory test results in 
order to enter information into the PHR (e.g. mg/dL for blood glucose or % for HbA1c).  
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As one participant noted, “I think it requires a lot of clicking to put in your history.”  
Participants did not perceive the PHR as a value add for their existing self-care behaviors.   
Theme 5: Out of sight, out of mind.  Participants shared a wide range of issues 
that limited opportunities to engage with the PHR, including personal illness, family and 
work responsibilities, temporary residential displacement, and traveling.  These issues 
proved to be major barriers to PHR use, resulting in participants forgetting their 
usernames or passwords and leading to non-use.  It is clear that the PHR was not viewed 
as a crucial tool in participants’ daily self-management of diabetes.  As one participant 
expressed, “I never got into the habit of doing it.  It was out of sight, out of mind.”   
Theme 6: Economic, infrastructure, and computer literacy barriers.  
Economic barriers including cost of Internet access and computer hardware problems 
inhibited PHR use.  One participant shared that he “got rid of my computer service 
[Internet access] because I couldn’t afford it.”  Other participants had their computer 
break down and did not have the financial resources to fix or replace it.  Participants also 
lacked alternate means of computer access if their primary access was unavailable (e.g. if 
their home computer broke, they could not use a work computer for personal use).  Even 
for participants with consistent access to a working computer, unstable Internet 
connectivity or slow speeds were barriers to PHR use.  One participant faced unreliable 
Internet connections at the public library, while another participant lived in a rural area 
with only a dial-up connection.  Finally, despite asking participants to self-identify being 
comfortable using a computer, issues related to computer literacy were expressed, 
exemplified by the comment, “I’m not a computer person so for me to get on to it, it took 
a while.” 
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Theme 7: I would have used it if I were sicker.  Some participants who were 
adequately managing their diabetes care believed the PHR was not needed because of 
their positive health status.  As one person shared, “my A1c has been steady.  So I didn’t 
feel like I really needed to use it as often…that wasn’t particularly useful for me.”  
Another participant believed he would have used the PHR if he was uncontrolled and/or 
needed to check his blood sugars more frequently, “I could see if I was trying to see trend 
lines, like if I did glucose daily or multiple times during the day.”   
Theme 8: Lack of patient-provider engagement with the PHR.  Most 
participants did not share the PHR with their physician.  Participants perceived that the 
“doctor already has all my information.”  Additionally, although all clinic providers 
were informed of their patients’ participation in the study, no participant discussed their 
provider asking to see the PHR or wanting to view it when asked by the participant.   
Theme 9: Privacy and security concerns.  Few participants voiced concerns 
about the privacy and security of information maintained in the PHR.  For those that did, 
concerns ranged from personal fears to technical questions.  One participant shared, “I’m 
a private person and dislike my entire life being recorded on some electronic device.”  
Another participant wondered if the PHR “is adequately secure enough, because it’s in 
the cloud and I’m always a little worried.  Are the insurance companies watching or how 
secure is it?  Those are part of my concerns.” 
Chapter 5. Discussion 
The quantitative findings did not indicate a statistically significant difference 
between either the control and intervention group or the PHR users and PHR non-users 
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from baseline to follow-up.  This lack of quantitative evidence of improvement is likely 
due to the identified barriers that emerged in the qualitative themes.     
There were a number of barriers that inhibit sustained and effective PHR use.  
These barriers must be addressed before the PHR can become a useful health technology.  
A few of these barriers, such as those described in the theme, Out of sight, out of mind, 
cannot be easily addressed or alleviated (e.g. personal illness or temporary residential 
displacement).  Nor can infrastructure or economic issues such as slow public Internet 
speeds, lack of high-speed Internet access in rural areas, or costs related to purchasing 
Internet access or repairing a broken computer.  Instead, focus should be placed on 
addressing those barriers that can be overcome.       
Barriers associated with PHR design can be addressed by incorporating the 
viewpoints and needs of patients.  This is particularly important given earlier research 
indicating that most standalone PHRs fail to meet even half of patient-identified desires 
(Fuji et al., 2012).  Poor usability also has a secondary “time cost” associated with it; if 
the PHR takes too much time to use, patients will be less likely to use it (illustrated by 
participants who negatively contrasted using the PHR with perceived easier record-
keeping tools such as written records) (Wynia & Dunn, 2010).  PHR usability can be 
enhanced by accounting for issues of health literacy, evidenced by participants’ difficulty 
with placing unit labels for laboratory test results (Detmer, Bloomrosen, Raymond, & 
Tang, 2008; Tang et al., 2006).  PHR designers should consider pre-populating unit labels 
and having the normal limits for each laboratory test indicated within the PHR.  PHR 
designers could also develop mobile platforms for PHRs, allowing individuals who are 
busy, traveling, or have limited time to sit down at a computer to engage with the PHR 
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on-the-go (Tom, Mangione-Smith, Solomon, & Grossman, 2012).  PHRs are not a “one-
size-fits-all” technology, and should possess functionalities that would bring value to 
patients with varying levels of engagement and need.  For example, providing tailored 
advice such as identification of potential drug-drug interactions could provide additional 
value and stimulate adoption among individuals who did not use the PHR because they 
perceived that they were already taking adequate care of their condition (Fuji et al., 2012; 
Tenforde et al., 2012; Tom et al., 2012).   
Security and privacy concerns were rarely discussed by participants despite being 
identified in the literature as a potentially large barrier to PHR use (Kaelber et al., 2008; 
Kahn et al., 2009; Wynia & Dunn, 2010).  Although unlikely due to participants’ high 
educational levels, participants in this study may not have expressed concern due to a 
lack of knowledge about potential negative consequences that could result from security 
and privacy issues with a PHR.  Alternatively, participants may simply be willing to 
accept security and privacy risks for the potential positive gains resulting from PHR use.  
Further exploration is needed to better understand what prompts security and privacy 
concerns by patients and what measures can be taken to address these concerns.   
 The qualitative themes also identified a lack of shared patient-provider 
engagement with the PHR.  It is clear that the PHR has not engaged providers to a great 
degree.  For the PHR to add value to care delivery and lead to clinical improvements, 
providers must become more educated about the PHR, promote its use as an important 
tool in patients’ diabetes care, and identify ways to use information in the PHR to 
enhance clinical decision-making.  It has been shown that a strong patient-provider 
relationship is associated with PHR adoption, and provider support may also help patients 
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identify how to integrate PHR use into their self-care routine (Agarwal, Anderson, 
Zarate, & Ward, 2013).  However, prior research has revealed that 25% of physicians did 
not know about PHRs, and 60% did not know if their patients used a PHR (Fuji, Galt, & 
Serocca, 2008).  Patients in this study indicated that their providers did not show interest 
in or ask to see the PHR despite all providers being aware their patients were using a 
PHR.  This is consistent with prior research where only 42% of physicians indicated a 
willingness to use a PHR in their practice (Wynia, Torres, & Lemieux, 2011).  
The qualitative themes also revealed that despite a lack of quantitative evidence of 
improvement, the PHR can still provide benefits to patients, namely, developing a 
complete and accessible record that was helpful for the patient, and enhancing awareness 
of their diabetes management.  Enhanced awareness led some participants to make 
modest behavioral changes, achieving some of the promise inherent in PHR use.  The 
PHR also helped patients at different levels of self-care engagement, from those who 
previously had not tracked their health information to patients who did so regularly.  The 
PHR did not replace existing health information record-keeping tools, as some 
participants either double-tracked their information or used the PHR as a supplementary 
record (e.g. to track yearly laboratory values while using other mechanisms to track daily 
blood glucose levels).  Thus, the PHR did not need to replace other mechanisms for it to 
be a useful health information management tool.   
It is important for all stakeholders to understand how patients and providers can 
benefit from a comprehensive, accurate PHR.  Patients have the potential to achieve the 
positive outcomes in this study (maintaining a complete record and enhanced awareness 
leading to behavioral change), while providers have a more complete picture of the 
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patient to fully inform medical decision-making (Smith et al., 2005; Witry, Doucette, 
Daly, Levy, & Chrischilles, 2010).  This is particularly important given the fact that not 
all electronic health record systems are interoperable, meaning that providers still possess 
an incomplete picture of the patient; information gaps that the PHR can help fill (Tang & 
Lansky, 2005).   
Limitations 
 The length of time between baseline and follow-up (3-6 months) may not have 
been sufficient for patients to establish the use of the PHR in their normal self-care 
management and routines, and then have the benefits of PHR use manifest in 
quantitatively measureable outcomes.  Future studies should utilize a similar mixed 
methods approach over at least a one year study period to better understand PHR use and 
allow sufficient time to observe quantitative changes.   
 The researchers were not able to obtain detailed information about PHR use (e.g. 
number of log-ins, number of times viewing a particular section within the PHR, etc.).  
Thus, the simple measure of whether or not a patient used the PHR even once after 
baseline was used to differentiate between PHR users and PHR non-users.  This simple 
measure may not have adequately captured the meaningful differences in PHR use that 
could lead to measureable changes in clinical and social cognitive outcomes.    
 This was a pilot study with a relatively small sample size that was only powered 
to detect changes in HbA1c.  Thus, it may have been underpowered to detect a potentially 
small effect size relative to the impact of the PHR on social cognitive factors.  
 The inclusion criteria of HbA1c  ≥6.0 meant that there was potentially less 
opportunity to detect meaningful changes in clinical outcomes (i.e. it is easier to 
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demonstrate clinical change from “poor to good” rather than “good to excellent”).  In 
order to address this potential limitation, a sub-analysis of participants with a HbA1c > 
7.0 was conducted.  It resulted in the identification of 64 participants (34 in the control 
group and 30 in the intervention group), and revealed no statistically significant 
difference between baseline and follow-up for HbA1c in either the control group (8.48% 
to 8.25%, p = .405) or the intervention group (9.10% to 8.87%, p = .375).   
Future Research Needs 
 Future research should focus on identifying and developing strategies for 
enhancing the PHR’s value and integrating it into a patient’s self-care routine.  Increased 
use of a mixed methods approach can help to identify potential predictors of PHR use and 
identify the key functions and features within a PHR that lead to actual quantitative 
clinical change.  Additionally, the benefits that emerged from PHR use in this study 
warrant further explanation.  In a longer-term study, it would be beneficial to explore if 
these benefits actually lead to clinical improvement, or if they result in non-tangible 
outcomes such as increased awareness that may or may not manifest itself through 
clinical outcomes.  
Conclusions 
Understanding of the potential PHRs have for facilitating patient knowledge gains 
and engagement in self-care, addressing usability and accessibility issues inherent in 
technology use, and educating providers about the benefits of PHR use are crucial for 
enhancing adoption and effective use of PHRs.   
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Figure 2.1. Intervention Mixed Methods Study Design Diagram 
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